Terms: = Gastric cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
2114 results:
1. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract] [Full Text] [Related]
2. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer.
Lin K; Wang Y; Liu F; You T; Liu X; Liu R; Li Z; Zhen C; Zhang Y; Liu X; Cai H
Eur J Med Res; 2024 Mar; 29(1):206. PubMed ID: 38539263
[TBL] [Abstract] [Full Text] [Related]
4.
Chen G; Shang J; Feng X; Li M; Zhang H; Liu J; Xu H
Anticancer Res; 2024 Apr; 44(4):1475-1485. PubMed ID: 38537964
[TBL] [Abstract] [Full Text] [Related]
5. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.
Zhang K; Xu Y; Chang X; Xu C; Xue W; Ding D; Nie M; Cai H; Xu J; Zhan L; Han J; Cai T; Ju D; Feng L; Zhang X; Yin K
Cancer Immunol Immunother; 2024 Mar; 73(4):75. PubMed ID: 38532108
[TBL] [Abstract] [Full Text] [Related]
6. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
7. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
PeerJ; 2024; 12():e17130. PubMed ID: 38515458
[TBL] [Abstract] [Full Text] [Related]
8. Identification roles of NFE2L3 in digestive system cancers.
Li F; Wen Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):150. PubMed ID: 38514488
[TBL] [Abstract] [Full Text] [Related]
9. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
10. cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis.
Li D; Huang P; Xia L; Leng W; Qin S
Int Immunopharmacol; 2024 Apr; 131():111836. PubMed ID: 38479160
[TBL] [Abstract] [Full Text] [Related]
11. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
13. HER2 targeted therapy in colorectal cancer: Current landscape and future directions.
Chen N; He L; Zou Q; Deng H
Biochem Pharmacol; 2024 May; 223():116101. PubMed ID: 38442793
[TBL] [Abstract] [Full Text] [Related]
14. Hsa_circ_0003356 suppresses gastric cancer progression via miR-556-5p/FKBP5 axis.
Lu C; Wu J; Li X; Huang W; Fang Y; Huang Y
Toxicol In Vitro; 2024 May; 97():105787. PubMed ID: 38401744
[TBL] [Abstract] [Full Text] [Related]
15. HER2
Hu HH; Wang SQ; Zhao H; Chen ZS; Shi X; Chen XB
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391024
[TBL] [Abstract] [Full Text] [Related]
16. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways.
Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
[TBL] [Abstract] [Full Text] [Related]
17. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
Baccili Cury Megid T; Baskurt Z; Ma LX; Barron CC; Farooq A; Saltiel MP; Wang X; Bach Y; Ayoama H; Jang RW; Chen E; Veit-Haibach P; Wang B; Kalimuthu S; Cotton J; Wong R; Mesci A; Elimova E
J Neurooncol; 2024 Mar; 167(1):111-122. PubMed ID: 38372902
[TBL] [Abstract] [Full Text] [Related]
18. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer.
Li F; Yan J; Leng J; Yu T; Zhou H; Liu C; Huang W; Sun Q; Zhao W
PeerJ; 2024; 12():e16911. PubMed ID: 38371373
[TBL] [Abstract] [Full Text] [Related]
19. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2.
Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
[TBL] [Abstract] [Full Text] [Related]
20. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.
Shen K; Xia W; Wang K; Li J; Xu W; Liu H; Yang K; Zhu J; Wang J; Xi Q; Shi T; Li R
J Cell Mol Med; 2024 Feb; 28(4):e18113. PubMed ID: 38332530
[TBL] [Abstract] [Full Text] [Related]
[Next]